Table 2 |
|||||
|
Identification of Lactobacillus plantarum 299v (Lp 299v) from biopsies and the antibiotics used |
|||||
|
Patient |
Lp 299v, first biopsy |
Lp 299v, later biopsies |
Antibiotics prior to ICU admission (≤ 12 days if not specified) |
Antibiotics in ICU before first biopsy |
Antibiotics in ICU (during biopsy period) |
|
|
|||||
|
Treatment group |
|||||
|
2 |
No |
Yes |
Erythromycin |
Erythromycin + imipenem |
Erythromycin + imipenem |
|
4 |
No |
No |
Cefuroxime |
Cefuroxime |
1 Imipenem, 2 +metronidazol |
|
5 |
No |
No |
Cefadroxile, 10 days |
Cefadroxile |
1 Cefuroxime, 2 meropenem |
|
10 |
No |
No |
Cefuroxime, 3 days |
Imipenem |
1 Imipenem, 2 +metronidazol |
|
12 |
No |
No |
No antibiotics |
Imipenem |
Imipenem |
|
14 |
No |
Yes |
1 Metronidazol + cefotaxime/cefuroxime, 2 -metronidazol, 3 -cefotaxime/cefuroxime; + imipenem; 12 days in total |
Imipenem |
Imipenem |
|
15 |
No |
Yes |
Ciprofloxacin + two doses metronidazol (rectally) |
Ceftazidime |
1 Ceftazidime, 2 +metronidazol |
|
17 |
No |
No |
Cefuroxime |
Imipenem |
Imipenem |
|
Control group |
|||||
|
1 |
No |
No |
Cloxacillin |
1 Cloxacillin, 2 cefuroxime |
1 Cefuroxime, 2 +metronidazol |
|
3 |
Yes |
No |
Imipenem |
Imipenem |
1 Imipenem, 2 +metronidazol |
|
6 |
Yes |
No |
1 Penicillin G, 2 erythromycin, 3 +netilmicin, 4 cefotaxime (-netilmicin, -erythromycin), 5 erythromycin, 6 imipenem; 3 weeks in total |
Imipenem |
Imipenem |
|
8 |
Yes |
No |
Penicillin G |
Imipenem |
1 Imipenem, 2 +clindamycin, 3 -clindamycin, +metronidazol, 4 vancomycin+ ciprofloxacin |
|
11 |
No |
No |
Metronidazol and cefuroxime |
Metronidazol and cefuroxime |
1 metronidazol + cefuroxime, 2 +isoniazid, 3 +rifampicin, 4 -(1, 2, 3), +imipenem |
|
13 |
Yes |
No |
1 PenicillinV, 2 cefuroxime; 6 days in total |
Cefuroxime |
Cefuroxime |
|
16 |
No |
No |
Cefuroxime |
Cefuroxime |
1 Cefuroxime, 2 penicillin G |
|
|
|||||
|
Figures indicate the order in which antibiotics were been given (and changed). +, added medication; -, withdrawn medication. ICU, intensive care unit. |
|||||
|
Klarin et al. Critical Care 2005 9:R285 doi:10.1186/cc3522 |
|||||